On 28 April, Fosun Pharma ('the Company', stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 (the reporting period). During the reporting period, the Company achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results